After the White House used a Sabrina Carpenter song without her permission, the pop star is keeping her response short and sweet. The "Espresso" singer, 26, took to X to slam the White House for using ...

Praluent and Repatha both lower bad cholesterol in certain people but have different approved uses and age limits. These drugs can have side effects like cold-like symptoms and injection site ...

Amgen AMGN2.38%increase; green up pointing triangle slashed the price of its cholesterol medication by more than half for U.S. patients through a new medication-access program amid the Trump ...

Amgen has joined the wave of major drugmakers setting up direct-to-consumer programs amid President Donald Trump’s call for more DTC options to lower U.S. drug prices. The "AmgenNow" program, launched ...

Please provide your email address to receive an email when new articles are posted on . Evolocumab will be made available to eligible patients via a new direct-to-consumer program. The PCSK9 inhibitor ...

Amgen (NASDAQ:AMGN) announced on Thursday that its PCSK9 inhibitor Repatha (evolocumab) reached the primary endpoints in a Phase 3 trial designed to evaluate its effect in reducing major adverse ...

On the heels of an FDA label expansion in August, Amgen is touting another potential avenue to extend the value of its decade-old PCSK9 cholesterol med Repatha. In the late-stage Vesalius-CV study, ...

President Donald Trump on Tuesday proposed using American cities, including Chicago, as training grounds for the armed forces and spoke of needing the U.S. military to combat what he called the ...

Repatha (evolocumab) is an injectable medicine that helps lower levels of low-density lipoprotein cholesterol (LDL), often called “bad” cholesterol. Approved in 2015, Repatha can now be used in adults ...

MINNEAPOLIS — Minnesota prosecutors filed misdemeanor disorderly conduct charges Tuesday against a woman accused of using a racist slur against a Black child at a playground — an incident the woman ...

The FDA has expanded approval of Amgen’s PCSK9 inhibitor Repatha (evolocumab), permitting use in adults at increased risk of major adverse cardiovascular events due to uncontrolled LDL cholesterol, ...

THOUSAND OAKS, Calif., Aug. 25, 2025 /PRNewswire/ -- Amgen (AMGN) today announced that the U.S. Food and Drug Administration (FDA) has broadened the approved use of Repatha ® (evolocumab) to include ...